EYPT

Eyepoint Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth 1/10
  • Value 0/10
Eyepoint sales and earnings growth
EYPT Growth
Low
  • Revenue Y/Y -27.50%
  • EPS Y/Y -36.64%
  • FCF Y/Y -86.70%
Eyepoint gross and profit margin trends
EYPT Profitability
Low
  • Gross margin 93.40%
  • EPS margin -739.40%
  • ROIC 5Y -182.78%
Eyepoint net debt vs free cash flow
EYPT Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage -7019.7

Eyepoint stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗